CBL — Control Bionics Cashflow Statement
0.000.00%
Last trade - 00:00- AU$24.75m
- AU$24.59m
- AU$7.04m
- 41
- 29
- 80
- 50
Annual cashflow statement for Control Bionics, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | -7.6 | -11.6 | -10.8 | -11 | -11 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -3.99 | -6.89 | -4.53 | -4.91 | -4.27 |
| Capital Expenditures | -0.053 | -0.148 | -0.458 | -0.473 | -0.442 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | — | — | — | — | -0.303 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -0.053 | -0.148 | -0.458 | -0.473 | -0.745 |
| Financing Cash Flow Items | -0.715 | 0 | — | -0.114 | -0.193 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 14.9 | -0.087 | 0.706 | 5.43 | 4.63 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 10.9 | -7.12 | -4.28 | 0.045 | -0.386 |